Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

J Infect Dis. 2004 Jan 15;189(2):254-7. Epub 2004 Jan 5.

PMID:
14722890
[PubMed - indexed for MEDLINE]
Free Article
2.

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

Vaccine. 2006 Jan 30;24(5):683-90. Epub 2005 Aug 24.

PMID:
16154241
[PubMed - indexed for MEDLINE]
3.

Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously.

Wong-Chew RM, García-León ML, Espinosa-Torres Torrija B, Hernández-Pérez B, Cardiel-Marmolejo LE, Beeler JA, Audet S, Santos-Preciado JI.

J Infect Dis. 2011 Aug 1;204(3):426-32. doi: 10.1093/infdis/jir278.

PMID:
21742842
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.

Dilraj A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, Coovadia HM, Bennett JV.

Lancet. 2000 Mar 4;355(9206):798-803.

PMID:
10711928
[PubMed - indexed for MEDLINE]
5.

Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.

Garly ML, Balé C, Martins CL, Monteiro M, George E, Kidd M, Dias F, Aaby P, Whittle HC.

Vaccine. 2001 Feb 28;19(15-16):1951-9.

PMID:
11228365
[PubMed - indexed for MEDLINE]
6.

Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.

Dilraj A, Sukhoo R, Cutts FT, Bennett JV.

Vaccine. 2007 May 22;25(21):4170-4. Epub 2007 Mar 20.

PMID:
17408818
[PubMed - indexed for MEDLINE]
7.

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.

Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2004 Jul 1;190(1):83-90. Epub 2004 May 26.

PMID:
15195246
[PubMed - indexed for MEDLINE]
Free Article
8.

Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.

Bennett JV, Fernandez de Castro J, Valdespino-Gomez JL, Garcia-Garcia Mde L, Islas-Romero R, Echaniz-Aviles G, Jimenez-Corona A, Sepulveda-Amor J.

Bull World Health Organ. 2002;80(10):806-12. Epub 2002 Nov 28.

PMID:
12471401
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.

Markowitz LE, Sepulveda J, Diaz-Ortega JL, Valdespino JL, Albrecht P, Zell ER, Stewart J, Zarate ML, Bernier RH.

N Engl J Med. 1990 Mar 1;322(9):580-7. Erratum in: N Engl J Med 1990 Mar 22;322(12):863.

PMID:
2304505
[PubMed - indexed for MEDLINE]
Free Article
10.

Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.

Pabst HF, Spady DW, Carson MM, Krezolek MP, Barreto L, Wittes RC.

Vaccine. 1999 Apr 9;17(15-16):1910-8.

PMID:
10217589
[PubMed - indexed for MEDLINE]
11.

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y.

JAMA. 1998 Aug 12;280(6):527-32.

PMID:
9707142
[PubMed - indexed for MEDLINE]
12.

Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.

Sabin AB, Flores Arechiga A, Fernández de Castro J, Albrecht P, Sever JL, Shekarchi I.

JAMA. 1984 May 11;251(18):2363-71.

PMID:
6368888
[PubMed - indexed for MEDLINE]
13.

A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.

Sepúlveda-Amor J, Valdespino-Gómez JL, García-García Mde L, Bennett J, Islas-Romero R, Echaniz-Aviles G, de Castro JF.

Vaccine. 2002 Jun 21;20(21-22):2790-5.

PMID:
12034106
[PubMed - indexed for MEDLINE]
14.

A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.

Simon JK, Pasetti MF, Viret JF, Mischler R, Muñoz A, Lagos R, Levine MM, Campbell JD.

Hum Vaccin. 2007 Mar-Apr;3(2):54-8. Epub 2007 Mar 10.

PMID:
17312403
[PubMed - indexed for MEDLINE]
Free Article
15.

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.

Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM.

Vaccine. 2003 Jul 28;21(24):3398-405. Review.

PMID:
12850348
[PubMed - indexed for MEDLINE]
16.

Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections.

Simasathien S, Migasena S, Bellini W, Samakoses R, Pitisuttitham P, Bupodom W, Heath J, Anderson L, Bennett J.

Vaccine. 1997 Feb;15(3):329-34.

PMID:
9139495
[PubMed - indexed for MEDLINE]
17.

Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire.

Cutts FT, Nyandu B, Markowitz LE, Forsey T, Zell ER, Othepa O, Wilkins K.

Vaccine. 1994 Nov;12(14):1311-6.

PMID:
7856296
[PubMed - indexed for MEDLINE]
18.

The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants.

Hussey GD, Goddard EA, Hughes J, Ryon JJ, Kerran M, Carelse E, Strebel PM, Markowitz LE, Moodie J, Barron P, Latief Z, Sayed R, Beatty D, Griffin DE.

J Infect Dis. 1996 Jun;173(6):1320-6.

PMID:
8648203
[PubMed - indexed for MEDLINE]
Free Article
19.

Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM.

J Infect Dis. 2013 Feb 15;207(4):574-82. doi: 10.1093/infdis/jis719. Epub 2013 Jan 8.

PMID:
23300162
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.

Job JS, Halsey NA, Boulos R, Holt E, Farrell D, Albrecht P, Brutus JR, Adrien M, Andre J, Chan E, et al.

Pediatr Infect Dis J. 1991 Apr;10(4):303-11.

PMID:
2062626
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk